- Generic name
- Atenolol
- Strength
- 50 mg
- Dosage form
- Tablet
- Manufactured by
- GlaxoSmithKline Bangladesh Ltd.
Lorten Tablet
About Lorten 50 mg Tablet
Lorten 50 mg tablets are made by GlaxoSmithKline Bangladesh Ltd. and contain atenolol, a beta-blocker used for heart and blood pressure conditions. It is available only on prescription.
There are 59 brands of Atenolol listed in Bangladesh. The lowest listed price is Betanol 25 mg Tablet at ৳ 0.45 per unit.
What is Lorten 50 mg Tablet?
Lorten is a 50 mg tablet from GlaxoSmithKline Bangladesh Ltd. that contains atenolol, a type of medicine known as a beta-adrenoceptor blocking drug. Beta-blockers act on the heart and blood vessels to reduce the workload on the heart. Atenolol is described as cardioselective, meaning it mainly affects the heart. Lorten is used in the management of high blood pressure, in the long-term management of angina (chest pain from the heart), and in some patients after a heart attack to lower the risk of death from heart problems. It is a prescription medicine and should only be taken under a doctor's care.
Uses of Lorten
Lorten is used to manage high blood pressure, either alone or with other blood pressure medicines. It is also used for the long-term management of angina pectoris. In addition, doctors may use it in hemodynamically stable patients with a definite or suspected acute myocardial infarction (heart attack) to reduce the risk of death from heart problems. Only a doctor can decide if it is suitable for a particular person.
How to use Lorten
Take Lorten exactly as your doctor prescribes. The dose and course are decided by your doctor and may be adjusted based on your pulse, blood pressure and other clinical observations. Do not change the dose or stop taking it on your own, because stopping suddenly can be harmful. Swallow the tablet as directed by your doctor. If you miss a dose, ask your doctor or pharmacist what to do. Keep all medicines out of the reach of children and do not use after the expiry date.
Side effects of Lorten
As with any beta-blocker, some people may experience slow heart rate (bradycardia) or low blood pressure (hypotension). Other possible side effects reported with beta-blockers include allergic reactions such as fever with aching and sore throat, breathing difficulties, and effects on the blood. Mental depression, disorientation, and short-term memory loss have also been reported. This is not a complete list. If you notice any unusual symptoms while taking Lorten, tell your doctor or pharmacist promptly.
Safety and precautions
Lorten is not suitable for everyone. It is contraindicated in people with sinus bradycardia, heart block greater than first degree, cardiogenic shock, or overt cardiac failure, and in those with a history of hypersensitivity to atenolol or any ingredient of the tablet. Pregnancy category is D, so caution is needed; it should be used in pregnancy only if the doctor decides it is necessary. It passes into breast milk and has been linked to significant bradycardia in breast-fed infants, so breastfeeding mothers should ask their doctor. People with impaired renal function or peripheral arterial circulatory disorders need caution. Elderly patients should be started cautiously. Always tell your doctor about other medicines you take and any health conditions before starting Lorten.
Frequently asked questions
Is Lorten safe during pregnancy or breastfeeding?
Atenolol is in pregnancy category D, which means it should be used during pregnancy only when the doctor decides it is necessary. It can pass into breast milk, and significant slow heart rate has been reported in breast-fed infants. Talk to your doctor before taking Lorten if you are pregnant, planning pregnancy, or breastfeeding.
What is Lorten used for and what kind of medicine is it?
Lorten contains atenolol, a beta-adrenoceptor blocking drug (beta-blocker). It is used to manage high blood pressure, for long-term management of angina, and in some stable patients after a heart attack to reduce the risk of death from heart problems. It is a prescription-only medicine.
What medicines may interact with Lorten?
Lorten may interact with catecholamine-depleting drugs such as reserpine, calcium channel blockers, disopyramide, and amiodarone. These interactions can increase the risk of low blood pressure, slow heart rate, or heart failure. Always tell your doctor or pharmacist about all medicines you are taking, including those bought without a prescription.
Who should not take Lorten?
Lorten should not be used by people with sinus bradycardia, heart block greater than first degree, cardiogenic shock, overt cardiac failure, or a history of hypersensitivity to atenolol or any component of the tablet. People with kidney problems or circulation problems should take it only with caution. Ask your doctor if it is right for you.
Also available as
Indications
- In the management of hypertension. It may be used alone or concomitantly with other antihypertensive agents, particularly with a thiazide-type diuretic.
- For the long-term management of patients with angina pectoris.
- In the management of hemodynamically stable patients with defnite or suspected acute myocardial infarction to reduce cardiovascular mortality.
Pharmacology
Dosage & Administration
Angina Pectoris: The initial dose of Atenolol is 50 mg given as one tablet a day. If an optimal response is not achieved within one week, the dosage should be increased to Atenolol 100 mg given as one tablet a day. Some patients may require a dosage of 200 mg once a day for optimal effect. Twenty-four hour control with once daily dosing is achieved by giving doses larger than necessary to achieve an immediate maximum effect. The maximum early effect on exercise tolerance occurs with doses of 50 to 100 mg, but at these doses the effect at 24 hours is attenuated, averaging about 50% to 75% of that observed with once a day oral doses of 200 mg.
Acute Myocardial Infarction: In patients with definite or suspected acute myocardial infarction, treatment with Atenolol I.V. Injection should be initiated as soon as possible after the patient's arrival in the hospital and after eligibility is established. Treatment should begin with the intravenous administration of 5 mg Atenolol over 5 minutes followed by another 5 mg intravenous injection 10 minutes later. In patients who tolerate the full intravenous dose (10 mg), Atenolol Tablets 50 mg should be initiated 10 minutes after the last intravenous dose followed by another 50 mg oral dose 12 hours later. Thereafter, Atenolol can be given orally either 100 mg once daily or 50 mg twice a day for a further 6-9 days or until discharge from the hospital. If bradycardia or hypotension requiring treatment or any other untoward effects occur, Atenolol should be discontinued.
Interaction
- Catecholamine-depleting drugs (eg, reserpine) may have an additive effect when given with beta-blocking agents. Patients treated with Atenolol plus a catecholamine depletor should therefore be closely observed for evidence of hypotension and/or marked bradycardia which may produce vertigo, syncope, or postural hypotension.
- Calcium channel blockers may also have an additive effect when given with Atenolol.
- Disopyramide is a Type I antiarrhythmic drug with potent negative inotropic and chronotropic effects. Disopyramide has been associated with severe bradycardia, asystole and heart failure when administered with beta blockers.
- Amiodarone is an antiarrhythmic agent with negative chronotropic properties that may be additive to those seen with beta blockers.
- Beta blockers may exacerbate the rebound hypertension which can follow the withdrawal of clonidine. If the two drugs are coadministered, the beta blocker should be withdrawn several days before the gradual withdrawal of clonidine. If replacing clonidine by beta-blocker therapy, the introduction of beta blockers should be delayed for several days after clonidine administration has stopped.
- Concomitant use of prostaglandin synthase inhibiting drugs, eg, indomethacin, may decrease the hypotensive effects of beta blockers.
- While taking beta blockers, patients with a history of anaphylactic reaction to a variety of allergens may have a more severe reaction on repeated challenge, either accidental, diagnostic or therapeutic. Such patients may be unresponsive to the usual doses of epinephrine used to treat the allergic reaction.
- Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. Concomitant use can increase the risk of bradycardia.
Contraindications
- Sinus bradycardia, heart block greater than first degree, cardiogenic shock, and overt cardiac failure.
- Those patients with a history of hypersensitivity to the atenolol or any of the drug product’s components.
Side Effects
- Hematologic: Agranulocytosis.
- Allergic: Fever, combined with aching and sore throat, laryngospasm, and respiratory distress.
- Central Nervous System: Reversible mental depression progressing to catatonia; an acute reversible syndrome characterized by disorientation of time and place; short term memory loss; emotional lability with slightly clouded sensorium; and, decreased performance on neuropsychometrics.
- Gastrointestinal: Mesenteric arterial thrombosis, ischemic colitis.
- Miscellaneous: There have been reports of skin rashes and/or dry eyes associated with the use of beta-adrenergic blocking drugs. Discontinuance of the drug should be considered if any such reaction is not otherwise explicable. Patients should be closely monitored following cessation of therapy.
- Other: Erythematous rash
Pregnancy & Lactation
Precautions & Warnings
Impaired Renal Function: The drug should be used with caution in patients with impaired renal function.
Geriatric Use:
- Hypertension and Angina Pectoris: Due to Coronary Atherosclerosis: Dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
- Acute Myocardial Infarction: Dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. Evaluation of patients with hypertension or myocardial infarction should always include assessment of renal function.
Overdose Effects
Storage Conditions
Alternative brands of Atenolol
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.